Last reviewed · How we verify
NCT06027463
The Predictive Value of Clinical Data on Perioperative and Postoperative Risk Events in Patients With Head and Neck Artery Stenosis
trial testing Head and neck vascular recanalization in Postoperative Risk Factors for Patients With Carotid Artery Stenosis in 1,500 participants. Suspended.
30 June 2026
Quick facts
| Lead sponsor | Tang-Du Hospital |
|---|---|
| Status | Suspended |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 1 December 2022 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Head and neck vascular recanalization
Conditions studied
- Postoperative Risk Factors for Patients With Carotid Artery Stenosis — all drugs for Postoperative Risk Factors for Patients With Carotid Artery Stenosis →
Sponsor
Tang-Du Hospital
Who can join
Adults 18 to 80, any sex, with Postoperative Risk Factors for Patients With Carotid Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Predictive Value of Clinical Data on Perioperative and Postoperative Risk Events in Patients With Head and Neck Artery Stenosis
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Integrating untargeted metabolomics and deep learning approaches to identify specific metabolic signatures and new mechanisms in unstable plaques.
Ma JQ, Wang L, Qu XP, Zhang Y, et al · · 2026 · PMID 42205783 · DOI 10.3389/fcvm.2026.1646067
Verify or expand the search:
- PubMed search for NCT06027463
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Tang-Du Hospital trials
Trials by the same sponsor.
- NCT07528235 — An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intraven · Phase 1 · not yet recruiting
- NCT07516522 — Intra-arterial Methylprednisolone After Endovascular Thrombectomy · Phase 2 · recruiting
- NCT07354061 — Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC) · Phase 1, PHASE2 · recruiting
- NCT07327736 — Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT · NA · not yet recruiting
- NCT07452601 — Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06027463 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tang-Du Hospital
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06027463.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing